Carnegie acted as exclusive financial adviser to the owners of Growth House Holding in the divestment to Orifarm Generics. Growth House is a highly successful developer, manufacturer and distributor of specialty and niche generic pharmaceuticals in the Nordic markets. July 2015.
Healthcare
Divestment of Growth House Holding A/S (DK) to Orifarm Generics A/S (DK) — Amount not disclosed
July 2015